Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1A | P08908 | 1/20 | 0.48 |
| ▸ | DRD2 | P14416 | 1/20 | 0.48 |
| ▸ | MAOA | P21397 | 2/20 | 0.44 |
| ▸ | MAOB | P27338 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.44 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.44 |
| ▸ | CASP1 | P29466 | 1/20 | 0.44 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 2/20 | 0.43 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.43 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.42 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.42 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.42 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL55137 | 0.87 | HTR1A (0.58) | HTR1ADRD2MAOAMAOBALDH1A1 | |
| SCHEMBL5542565 | 0.86 | HTR1A (0.48) | HTR1ADRD2MAOAMAOBALDH1A1 | |
| SCHEMBL9219290 | 0.83 | ESR1 (0.56) | HTR1AALDH1A1NR1H3TDP1TAAR1 | |
| SCHEMBL28918313 | 0.83 | TAAR1 (0.43) | HTR1ADRD2MAOBHTR2ATAAR1 | |
| SCHEMBL28438552 | 0.82 | HTR1A (0.46) | HTR1ADRD2MAOAMAOBALDH1A1 | |
| SCHEMBL132297 | 0.79 | HSPA5 (0.38) | ALOX12CYP2A6TAAR1 | |
| SCHEMBL27923108 | 0.78 | HTR2A (0.54) | HTR1ADRD2MAOAMAOBALDH1A1 | |
| SCHEMBL3244924 | 0.78 | HTR2A (0.56) | DRD2HPGDALOX15HSD17B10HTR2A | |
| SCHEMBL2996327 | 0.78 | HTR2A (0.68) | HTR1ADRD2MAOAMAOBALDH1A1 | |
| SCHEMBL5543918 | 0.77 | MAOB (0.56) | MAOAMAOBALDH1A1HPGDALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111491963-B | Method for producing (meth) acrylic composition, coating material containing (meth) acrylic composition, and cured body | 三菱瓦斯化学株式会社 | 2023-04-28 | — | — | CN | disclosed |
| US-20220145118-A1 | (METH)ACRYLIC COMPOSITION, PAINT AND CURING AGENT COMPRISING SAME | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-05-12 | — | — | US | disclosed |
| US-11326073-B1 | (meth)acrylic composition, paint and curing agent comprising same | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2022-05-10 | — | — | US | disclosed |
| CN-108822245-B | (meth) acrylic acid-based copolymer | 三菱瓦斯化学株式会社 | 2021-02-12 | — | — | CN | disclosed |
| WO-2020218151-A1 | (METH)ACRYLIC COMPOSITION, PAINT AND CURING AGENT COMPRISING SAME | 三菱瓦斯化学株式会社 | 2020-10-29 | — | — | WO | disclosed |
| US-20190338157-A1 | (METH)ACRYLIC COMPOSITION, COATING MATERIAL CONTAINING SAME AND CURED BODY | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2019-11-07 | — | — | US | disclosed |
| EP-3495397-A1 | (METH)ACRYLIC COMPOSITION, COATING MATERIAL CONTAINING SAME AND CURED BODY | Mitsubishi Gas Chemical Company, Inc. (JP) | 2019-06-12 | — | — | EP | disclosed |
| US-10150865-B2 | Resin composition and molded object obtained therefrom | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2018-12-11 | — | — | US | disclosed |
| CN-108822245-A | （Methyl）Acrylic copolymer | 三菱瓦斯化学株式会社 | 2018-11-16 | — | — | CN | disclosed |
| CN-105705580-B | (meth) acrylic copolymer, resin composition, and molded article thereof | 三菱瓦斯化学株式会社 | 2018-07-20 | — | — | CN | disclosed |
| EP-3279259-A1 | RESIN COMPOSITION AND MOLDED OBJECT OBTAINED THEREFROM | Mitsubishi Gas Chemical Company, Inc. (JP) | 2018-02-07 | — | — | EP | disclosed |
| CN-106459553-B | Poly carbonate resin composition and its formed body | 三菱瓦斯化学株式会社 | 2018-01-19 | — | — | CN | disclosed |
| US-20170327685-A1 | RESIN COMPOSITION AND MOLDED OBJECT OBTAINED THEREFROM | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2017-11-16 | — | — | US | disclosed |
| CN-106459553-A | Polycarbonate resin composition and article molded therefrom | 三菱瓦斯化学株式会社 | 2017-02-22 | — | — | CN | disclosed |
| CN-105705580-A | (meth) acrylic copolymer, resin composition, and molded article thereof | 三菱瓦斯化学株式会社 | 2016-06-22 | — | — | CN | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| EP-1555267-B1 | 2,3-DIHYDRO-6-NITROIMIDAZO[2,1-b]OXAZOLES | OTSUKA PHARMA CO LTD (JP) | 2013-01-16 | — | — | EP | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | HTR1A 4141/4885DRD2 542/4885MAOA 2885/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.